Abstract
Muscimol, a psychoactive isoxazole from Amanita muscaria and related mushrooms, has proved to be a remarkably selective agonist at ionotropic receptors for the inhibitory neurotransmitter GABA. This historic overview highlights the discovery and development of muscimol and related compounds as a GABA agonist by Danish and Australian neurochemists. Muscimol is widely used as a ligand to probe GABA receptors and was the lead compound in the development of a range of GABAergic agents including nipecotic acid, tiagabine, 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol, (Gaboxadol®) and 4-PIOL.
Similar content being viewed by others
References
Wieland T (1968) Poisonous principles of mushrooms of the genus Amanita. Science 159:946–952
Wasson RG (1968) Soma: Divine Mushroom of Immortality. Harcourt Brace Jovanovich, New York
DeFeudis FV (1980) Physiological and behavioral studies with muscimol. Neurochem Res 5:1047–1068
Eugster CH, Takemoto T (1967) Zür Nomenclature der neuen Verbindungen aus Amanita-Arten. Helv Chim Acta 50:126–127
Johnston GAR, Curtis DR, De Groat WC, Duggan AW (1968) Central actions of ibotenic acid and muscimol. Biochem Pharmacol 17:2488–2489
Curtis DR, Hösli L, Johnston GAR (1967) Inhibition of spinal neurons by glycine. Nature 215:1502–1503
Curtis DR, Duggan AW, Felix D, Johnston GAR (1971) Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res 32:69–96
Johnston GAR, GABA chemistry: Analogs of GABA as therapeutic and investigational agents, in GABA In The Nervous System: The View At Fifty Years, D.L. Martin and R. Olsen, Editors. 2000, Lippincott Williams and Wilkins: Philadelphia. p. 65-80.
Brehm L, Hjeds H, Krogsgaard-Larsen P (1972) The structre of muscimol, a GABA analogue of restricted conformation. Acta Chem Scand 26:1298–1299
Curtis DR (2006) David R. Curtis Autobiography. The History of Neuroscience in Autobiography 5:171–225
Krogsgaard-Larsen P, Johnston GAR, Curtis DR, Game CJA, McCulloch RM (1975) Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem 25:803–809
Chebib M, Johnston GAR (2000) GABA-activated ligand gated ion channels: medical chemistry and molecular biology. J Med Chem 43:1427–1447
Johnston GAR (2013) Advantages of an antagonist: bicuculline and other GABA antagonists. Br J Pharmacol 169:328–336
Beart PM, Curtis DR, Johnston GAR (1971) 4-Aminotetrolic acid: new conformational-restricted analogue of γ-aminobutyric acid. Nature - New Biology 234:80–81
Johnston GAR, Curtis DR, Beart PM, Game CJA, McCulloch RM, Twitchin B (1975) Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem 24:157–160
Johnston GAR, Chebib M, Hanrahan JR, Mewett KN (2010) Neurochemicals for the investigation of GABAC receptors. Neurochem Res 35:1970–1977
Snodgrass SR (1978) Use of 3H-muscimol for GABA receptor studies. Nature 273:392–394
Krogsgaard-Larsen P, Johnston GAR (1978) Structure-activity studies on the inhibition of GABA binding to rat brain membranes by muscimol and related compounds. J Neurochem 30:1377–1382
Johnston GAR (1971) Muscimol and the uptake of γ-aminobutyric acid by rat brain slices. Psychopharmacologia 22:230–233
Johnston GAR, Kennedy SM, Lodge D (1978) Muscimol uptake, release and binding in rat brain slices. J Neurochem 31:1519–1523
Woodward RM, Polenzani L, Miledi R (1993) Characterization of bicuculline/baclofen-insensitive (ρ-like) γ-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of γ-aminobutyric acidA and γ-aminobutyric acidB receptor agonists and antagonists. Mol Pharmacol 43:609–625
Ebert B, Thompson SA, Saounatsou K, McKernan R, Krogsgaard-Larsen P, Wafford KA (1997) Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human γ-aminobutyric acid type A receptors. Mol Pharmacol 52:1150–1156
Storustovu SI, Ebert B (2006) Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J Pharmacol Exp Ther 316:1351–1359
Mortensen M, Ebert B, Wafford K, Smart TG (2010) Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors. J Physiol 588:1251–1268
DeFeudis FV (1980) Binding stuides with muscimol; Relation to synaptic γ-aminobutrate receptors. Neuroscience 5:675–688
Baur R, Sigel E (2003) On high- and low-affinity agonist sites in GABAA receptors. J Neurochem 87:325–332
Andrews PR, Johnston GAR (1979) Conformational analysis of muscimol, a GABA agonist. J Theor Biol 79:263–273
Bergmann R, Kongsbak K, Sorensen PL, Sander T, Balle T (2013) A unified model of the GABA(A) receptor comprising agonist and benzodiazepine binding sites. PLoS ONE [Electronic Resource] 8:e52323
Karim N, Wellendorph P, Absalom N, Bang LH, Jensen ML, Hansen MM, Lee HJ, Johnston GAR, Hanrahan JR, Chebib M (2012) Low nanomolar GABA effects at extrasynaptic alpha4beta1/beta3delta GABAA receptor subtypes indicate a different binding mode for GABA at these receptors. Biochem Pharmacol 84:549–557
Krogsgaard-Larsen P, Johnston GAR (1975) Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem 25:797–802
Brehm L, Krogsgaard-Larsen P, Johnston GAR, Schaumburg K (1976) X-Ray crystallographic and proton magnetic resonance spectorscopic investigations of nipecotic acid, a potent inhibitor of γ-aminobutyric acid (GABA) uptake. Acta Chem. Scand. B 30:542–548
Johnston GAR, Stephanson AL, Twitchin B (1976) Uptake and release of nipecotic acid by rat brain slices. J Neurochem 26:83–87
Johnston GAR, Krogsgaard-Larsen P, Stephanson AL, Twitchin B (1976) Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optical isomers of nipecotic acid. J Neurochem 26:1029–1032
Juhasz G, Kekesi KA, Nyitral G, Dobolyl A, Krogsgaard-Larsen P, Schousboe A (1997) Differential effects of nipecotic acid and 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol on extracellular γ-aminobutyrate levels in rat thalamus. Eur J Pharmacol 331:139–144
Falch E, Perregaard J, Frølund B, Sokilde B, Buur A, Hansen LM, Frydenvang K, Brehm L, Bolvig T, Larsson OM, Sanchez C, White HS, Schousboe A, Krogsgaard LP (1999) Selective inhibitors of glial GABA uptake: synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J Med Chem 42:5402–5414
Falch E, Krogsgaard-Larsen P (1989) GABA uptake inhibitors containing mono- and diarylmethoxyalkyl N-subsitutents. Drug Design & Delivery 4:205–215
Andersen KE, Braestrup C, Gronwald FC, Jorgensen AS, Nielsen EB, Sonnewald U, Sorensen PO, Suzdak PD, Knutsen LJ (1993) The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl)-3-thienyl-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. J Med Chem 36:1716–1725
Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowki C (1964) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269:219–224
Schousboe A, Madsen KK, White HS (2011) GABA transport inhibitors and seizure protection: the past and future. Future Medicinal Chemistry 3:183–187
Schousboe A, Madsen KK, Barker-Haliski ML, and White HS (2014) The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters. Neurochemical Research: in press this issue
Krogsgaard-Larsen P, Johnston GAR, Lodge D, Curtis DR (1977) A new class of GABA agonist. Nature 268:53–55
Krehan D, Frølund B, Ebert B, Nielsen B, Krogsgaard-Larsen P, Johnston GAR, Chebib M (2003) Aza-THIP and related analogues of THIP as GABAC antagonists. Bioorganic and Medicinal Chemistry 11:4891–4896
Skerritt JH, Johnston GAR (1983) Diazepam stimulates the binding of GABA and muscimol but not THIP to rat brain membranes. Neurosci Lett 38:315–320
Krogsgaard-Larsen P, Frolund B, Liljefors T, Ebert B (2004) GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem Pharmacol 68:1573–1580
Lancel M, Faulhaber J (1996) The GABA(a) agonist THIP (gaboxadol) increases non-rem sleep and enhances delta activity in the rat. NeuroReport 7:2241–2245
Frølund B, Kristiansen U, Brehm L, Hansen AB, Krogsgaard-Larsen P, Falch E (1995) Partial GABAA receptor agonists. Synthesis and in vitro pharmacology of a series of nonannulated analogs of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol. J Med Chem 38:3287–3296
Frølund B, Tagmose L, Jorgensen AT, Kristiansen U, Stensbol TB, Liljefors T, Krogsgaard-Larsen P (2003) Design and synthesis of a new series of 4-alkylated 3-isoxazolol GABA A antagonists. Eur J Med Chem 38:447–449
Hoestgaard-Jensen K, O’Connor RM, Dalby NO, Simonsen C, Finger BC, Golubeva A, Hammer H, Bergmann ML, Kristiansen U, Krogsgaard-Larsen P, Brauner-Osborne H, Ebert B, Frølund B, Cryan JF, Jensen AA (2013) The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors. Br J Pharmacol 170:919–932
49. Peterson JG, Bergmann R, Krogsgaard-Larsen P, Balle T, and Frølund B (2014) Probing the orthosteric binding site of GABAA receptors with heterocyclic GABA carboxylic acid bioisosteres. Neurochemical Research:in press
Acknowledgments
I thank my many Danish colleagues, particularly the Krogsgaard-Larsen family, for their friendship over many years. I am grateful to Phil Beart, Jane Hanrahan and Ken Mewett for their helpful comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Special Issue: In honor of Krogsgaard-Larsen.
Rights and permissions
About this article
Cite this article
Johnston, G.A.R. Muscimol as an Ionotropic GABA Receptor Agonist. Neurochem Res 39, 1942–1947 (2014). https://doi.org/10.1007/s11064-014-1245-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-014-1245-y